TY - JOUR T1 - μ-Opioid Receptor Internalization: Opiate Drugs Have Differential Effects on a Conserved Endocytic Mechanism <em>In Vitro</em> and in the Mammalian Brain JF - Molecular Pharmacology JO - Mol Pharmacol SP - 377 LP - 384 DO - 10.1124/mol.53.3.377 VL - 53 IS - 3 AU - Duane E. Keith AU - Benito Anton AU - Stephen R. Murray AU - Paulette A. Zaki AU - Peter C. Chu AU - Dmitri V. Lissin AU - Ghislaine Monteillet-Agius AU - Phoebe L. Stewart AU - Christopher J. Evans AU - Mark von Zastrow Y1 - 1998/03/01 UR - http://molpharm.aspetjournals.org/content/53/3/377.abstract N2 - μ-Opioid receptors are the pharmacological targets of endogenous opioid peptides and morphine-like alkaloid drugs. Previous studies of transfected cells and peripheral neurons indicate that opioid receptors are rapidly internalized after activation by the alkaloid agonist etorphine but not after activation by morphine. To determine whether opioid receptors in the central nervous system are regulated by a similar process of agonist-selective internalization, μ-opioid receptors were examined in rat brain neurons after treatment of animals with opioid drugs. Internalized μ receptors were observed within 30 min after intraperitoneal injection of the alkaloid agonist etorphine, and this process was blocked by the antagonist naloxone. Colocalization of internalized opioid receptors with transferrin receptors in confocal optical sections indicated that receptor internalization observedin vivo is mediated by a membrane trafficking pathway similar to that observed previously in vitro using transfected human embryonic kidney 293 cells. Morphine failed to induce detectable rapid internalization of receptors, even when administered to animals at doses far in excess of those required to induce analgesia. To quantify these agonist-selective differences and to analyze an array of opioid ligands for their ability to trigger internalization, we used flow cytometry on stably transfected 293 cells. These studies indicated that the different effects of individual agonists are not correlated with their potencies for receptor activation and that a variety of clinically important agonists differ significantly in their relative abilities to stimulate the rapid internalization of opioid receptors. ER -